IDiyas

For the Inventor, By the Inventor

Salem, CT, United States of America

Shu Yu

USPTO Granted Patents = 11

Average Co-Inventor Count = 6.0

ph-index = 4

Forward Citations = 59(Granted Patents)


Location History:

  • Salem, CT (US) (2020 - 2024)
  • Groton, CT (US) (2024)

Company Filing History:

goldMedal11 out of 4,455 
 
Pfizer Corporation
 patents

Years Active: 2020-2025

Loading Chart...
11 patents (USPTO):
1. 12297177 - Solid state forms of (S)-2-(((S)-6,8-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)amino)-N-(1-(2-methyl-1-(neopentylamino)propan-2-yl)-1H-imidazol-4-yl)pentanamide and uses thereof (2025-05-13),
2. 12116347 - Solid state forms of (S)-2-(((S)-6,8-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)amino)-N-(1-(2-methyl-1-(neopentylamino)propan-2-yl)-1H-imidazol-4-yl)pentanamide and uses thereof (2024-10-15),
3. 11905255 - Solid state forms of (S)-2-(((S)-6,8-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)amino)-N-(1-(2-methyl-1-(neopentylamino)propan-2-yl)-1H-imidazol-4-yl)pentanamide and uses thereof (2024-02-20),
4. 11884635 - Solid state forms of (S)-2-(((S)-6,8-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)amino)-N-(1-(2-methyl-1-(neopentylamino)propan-2-yl)-1H-imidazol-4-yl)pentanamide and uses thereof (2024-01-30),
5. 11884634 - Compositions of solid forms of (S)-2-(((S)-6,8-difluoro-1,2,3,4- tetrahydronaphthalen-2-yl)amino)-N-(1-(2-methyl-1-(neopentylamino)propan-2-yl)-1H-imidazol-4-yl)pentanamide (2024-01-30),
6. 11845732 - Solid state forms of (S)-2-(((S)-6,8-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)amino)-N-(1-(2-methyl-1-(neopentylamino)propan-2-yl)-1H-imidazol-4-yl)pentanamide and uses thereof (2023-12-19),
7. 11820748 - Solid state forms of (S)-2-(((S)-6,8-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)amino)-N-(1-(2-methyl-1-(neopentylamino)propan-2-yl)-1H-imidazol-4-yl)pentanamide and uses thereof (2023-11-21),
8. 11566006 - Solid state forms of (S)-2-(((S)-6,8-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)amino)-N-(1-(2-methyl-1-(neopentylamino)propan-2-yl)-1H-imidazol-4-yl)pentanamide and uses thereof (2023-01-31),
9. 10941118 - Solid state forms of (S)-2-(((S)-6,8-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)amino)-N-(1-(2-methyl-1-(neopentylamino)propan-2-yl)-1H-imidazol-4-yl)pentanamide and uses thereof (2021-03-09),
10. 10710966 - Solid state forms of (S)-2-(((S)-6,8-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)amino)-N-(1-(2-methyl-1-(neopentylamino)propan-2-yl)-1H-imidazol-4-yl)pentanamide and uses thereof (2020-07-14),
11. 10590087 - Solid state forms of (S)-2-(((S)-6,8-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)amino)-N-(1-(2-methyl-1-(neopentylamino)propan-2-yl)-1H-imidazol-4-yl)pentanamide and uses thereof (2020-03-17),

Title: **Innovative Contributions of Inventor Shu Yu in Pharmaceutical Sciences**

Introduction

Shu Yu, a prominent inventor based in Salem, Connecticut, has made significant strides in the field of pharmaceutical sciences. With ten patents to his name, he is known for his innovative approaches to drug formulation and cancer treatment. His work has contributed to advancements in therapy for various tumors and cancers, showcasing the critical role of inventors in healthcare innovation.

Latest Patents

One of Shu Yu's latest patents focuses on solid-state forms of a novel compound, specifically (S)-2-(((S)-6,8-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)amino)-N-(1-(2-methyl-1-(neopentylamino)propan-2-yl)-1H-imidazol-4-yl)pentanamide. This patent encompasses several key aspects, including:

a) Solid-state forms of hydrobromide salts of the compound;

b) Pharmaceutical compositions utilizing these solid-state forms, optionally including a pharmaceutically acceptable carrier;

c) Methods for treating tumors or cancers by administering these solid-state forms to patients in need;

d) Techniques for preparing these solid-state forms of the compound.

This breakthrough has the potential to enhance therapeutic options in oncology.

Career Highlights

Shu Yu works at Pfizer Corporation, a global leader in biopharmaceuticals. His dedication to research and development has enabled him to achieve remarkable success in patenting his inventions. His innovative work is recognized not only for its scientific merit but also for its potential impact on patient treatment paradigms.

Collaborations

Throughout his career, Shu Yu has collaborated with several professionals, including Elaine Greer and Stephen Anderson. These partnerships have fostered an environment of creativity and innovation, leading to the successful development of new pharmaceutical compositions and treatment methods.

Conclusion

Inventor Shu Yu exemplifies the qualities of a pioneering innovator in the pharmaceutical industry. His contributions, particularly through his recent patents, are not only important for scientific advancement but also represent hope for improved cancer therapies. As innovations continue to evolve in this field, Shu Yu's work serves as a beacon for aspiring inventors and researchers dedicated to making a difference in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…